Avantor Completes Acquisition of Masterflex
Following the acquisition, Avantor will have access to Masterflex’s various bioproduction operations.
Avantor announced on Nov. 1, 2021, that it had completed a previously announced acquisition of the Masterflex bioprocessing business and its related assets from Antylia Scientific, a portfolio company. Masterflex is an Illinois-based manufacturer of peristaltic pumps and aseptic single-use fluid transfer technologies.
According to a company press release, the Masterflex acquisition is intended to strengthen Avantor's offering in bioproduction platforms such as monoclonal antibodies, cell and gene therapy, and messenger-ribonucleic acid. Masterflex also supports both therapy and vaccine manufacturing, including those related to COVID-19.
"The acquisition of Masterflex extends Avantor's single-use offering and gives us a complete end-to-end solution for aseptic fluid transfer throughout the bioproduction workflow," said Michael Stubblefield, president and CEO of Avantor, in a company press release. "The acquisition demonstrates our commitment to the growing biopharma market and to providing more comprehensive solutions to some of the world's most complex challenges in therapy and vaccine development."
Source: Avantor
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
